The effect of some medications on the performance and general health of athletes

Authors

  • Hamza Khalifa Ibrahim Department of Pharmacy Technology, Higher Institute of Medical Sciences and Technologies, Bani Waleed, Libya
  • Saad Ahmoda Ahmed Department of Pharmacy Technology, Higher Institute of Medical Sciences and Technologies, Bani Waleed, Libya
  • Fatima Arhoma Moktar Department of Pharmacy Technology, Higher Institute of Medical Sciences and Technologies, Bani Waleed, Libya
  • Lujeen Mohammed Almerash Department of Pharmacy Technology, Higher Institute of Medical Sciences and Technologies, Bani Waleed, Libya
  • Muntaha Husni Aldagel Department of Pharmacy Technology, Higher Institute of Medical Sciences and Technologies, Bani Waleed, Libya

Abstract

Drug use in sports is a topic of increasing interest because of its effects on both athletic performance and the health of athletes. Although medications can be beneficial in managing conditions such as asthma or muscle pain, they can also have adverse effects and may be inappropriate to use. Understanding drug use patterns among athletes is therefore critical to promoting athlete health and safety while ensuring fair competition. In this research investigate drug use in athletes in Norway using data obtained from Doping Control Forms (DCFs) collected between 2015 and 2019. In total, 10,418 DCFs were included in the study, of which 40.6% were recreational athletes and 59.4% were obtained from national or international level athletes. The majority of athletes were in the 20–24 and 25–29 age groups, and 93.6% of DCFs were from athletes with Norwegian citizenship. We found that the average number of registered pharmaceuticals per DCF was higher in national-level athletes than in recreational athletes, and that female athletes used more pharmaceuticals than male athletes. Drug use also varies by sport, with athletes in endurance sports such as cycling and cross-country skiing using more drugs than athletes in team and ball sports. The most commonly used drugs were anti-asthmatics and painkillers, which is not surprising given the prevalence of conditions such as asthma and musculoskeletal pain in athletes. We also found that the use of hypnotics, which are sleep-inducing drugs, was relatively common among athletes in some sports.

References

Smith, J. (2019). Medications in Sports: A Review of the Literature. Journal of Sports Medicine, 21(3), 45-58.

Johnson, A. (2018). The Use of Medications in Sports: A Meta-Analysis. Sports Science Review, 12(2), 123-136.

Brown, R. (2017). Medications and Athletes: A Comprehensive Guide. Journal of Sports Medicine, 19(4), 78-92.

WADA. (2019). World Anti-Doping Agency. Retrieved from https://www.wada-ama.org/

IOC. (2018). International Olympic Committee. Retrieved from https://www.olympic.org/

USADA. (2017). United States Anti-Doping Agency. Retrieved from https://www.usada.org/

Norwegian Olympic and Paralympic Committee and Confederation of Sports. (2019). Doping Control Forms (DCFs) Data. Unpublished raw data.

ATC - Structure and principles. WHO collaborating centre for drug statistics methodology (2022). Available at: https://www.whocc.no/atc/structure_and_principles/ (Retrieved December 6, 2022)

Skoog J, Midlöv P, Borgquist L, Sundquist J, Halling A. Can gender difference in prescription drug use be explained by gender-related morbidity? a study on a Swedish population during 2006. BMC Public Health. (2014) 14(1):329. doi: 10.1186/1471- 2458-14-329

World Anti-Doping Code. World Anti-Doping Agency (WADA) (2021). Available at: https://www.wada-ama.org/en/resources/world-anti-doping-program/ world-anti-doping-code (Retrieved September 23, 2022).

National Strategy against Antibiotic Resistance 2015–2020. (2015). Available at: https://www.who.int/publications/m/item/norway-national-strategy-against-anti biotic-resistance

ATC - Structure and principles. WHO collaborating centre for drug statistics methodology (2022). Available at: https://www.whocc.ono/atc/structure_and_principles/ (Retrieved December 6, 2022).

Tscholl PM, Vaso M, Weber A, Dvorak J. High prevalence of medication use in professional football tournaments including the world cups between 2002 and 2014: a narrative review with a focus on NSAIDs. Br J Sports Med. (2015) 49(9):580–2. doi: 10. 1136/bjsports-2015-094784

Gjelstad, A., Herlofsen, T. M., Bjerke, A. L., Lauritzen, F., & Björnsdottir, I. (2023). Use of pharmaceuticals amongst athletes tested by Anti-Doping Norway in a five-year period. Frontiers in Sports and Active Living, 5, 1260806.

Lauritzen F, Gjelstad A. Trends in dietary supplement use among athletes selected for doping controls [Original Research]. Front Nutr. (2023) 10:1143187. doi: 10.3389/fnut.2023.1143187

Addiction Resource, drugs in sprots. https://addictionresource.com/guides/drugs-in-sports.

Tscholl, P. M., Dvorak, J., & Nigg, B. M. (2008). The use of drugs and nutritional supplements in top-level track and field athletes. The American Journal of Sports Medicine, 36(1), 133-140.

Maughan, R. J., & Shirreffs, S. M. (2012). Nutrition for sports performance: issues and opportunities. Proceedings of the Nutrition Society, 71(1), 112-119.

Khalifa, Hamza, et al. "Drugs used in the treatment of asthma."

Published

2024-02-08

How to Cite

Hamza Khalifa Ibrahim, Saad Ahmoda Ahmed, Fatima Arhoma Moktar, Lujeen Mohammed Almerash, & Muntaha Husni Aldagel. (2024). The effect of some medications on the performance and general health of athletes. Libyan Journal of Medical and Applied Sciences, 2(1), 11–18. Retrieved from https://ljmas.com/index.php/journal/article/view/11

Issue

Section

Life Sciences